Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV
出版年份 2016 全文链接
标题
Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV
作者
关键词
Viral load, Viral replication, HIV, Antiretroviral therapy, Outgrowth assay, Viral persistence and latency, T cells, Viremia
出版物
PLoS Pathogens
Volume 12, Issue 4, Pages e1005535
出版商
Public Library of Science (PLoS)
发表日期
2016-04-28
DOI
10.1371/journal.ppat.1005535
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Persistent HIV-1 replication maintains the tissue reservoir during therapy
- (2016) Ramon Lorenzo-Redondo et al. NATURE
- HIV-1 Integration Landscape during Latent and Active Infection
- (2015) Lillian B. Cohn et al. CELL
- Viremic Relapse after HIV-1 Remission in a Perinatally Infected Child
- (2015) Katherine Luzuriaga et al. NEW ENGLAND JOURNAL OF MEDICINE
- Post-treatment control of HIV infection
- (2015) Jessica M. Conway et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption
- (2015) Meghan K. Rothenberger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Towards an HIV-1 cure: measuring the latent reservoir
- (2015) Katherine M. Bruner et al. TRENDS IN MICROBIOLOGY
- HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days—Implications for HIV Remission
- (2015) Mykola Pinkevych et al. PLoS Pathogens
- Antiretroviral-Free HIV-1 Remission and Viral Rebound After Allogeneic Stem Cell Transplantation
- (2014) Timothy J. Henrich et al. ANNALS OF INTERNAL MEDICINE
- Stochastic variability in HIV affects viral eradication: Fig. 1.
- (2014) Igor M. Rouzine et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1
- (2014) Alison L. Hill et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection
- (2014) T. A. Wagner et al. SCIENCE
- Specific HIV integration sites are linked to clonal expansion and persistence of infected cells
- (2014) F. Maldarelli et al. SCIENCE
- Loss and Recovery of Genetic Diversity in Adapting Populations of HIV
- (2014) Pleuni S. Pennings et al. PLoS Genetics
- Lack of Detectable HIV-1 Molecular Evolution during Suppressive Antiretroviral Therapy
- (2014) Mary F. Kearney et al. PLoS Pathogens
- Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial
- (2014) Thomas A Rasmussen et al. Lancet HIV
- Hematopoietic cell transplantation and HIV cure: where we are and what next?
- (2013) S. Zou et al. BLOOD
- Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure
- (2013) Ya-Chi Ho et al. CELL
- A Pilot Study Assessing the Safety and Latency-Reversing Activity of Disulfiram in HIV-1-Infected Adults on Antiretroviral Therapy
- (2013) A. M. Spivak et al. CLINICAL INFECTIOUS DISEASES
- Plasma Viremia and Cellular HIV-1 DNA Persist Despite Autologous Hematopoietic Stem Cell Transplantation for HIV-Related Lymphoma
- (2013) Anthony R. Cillo et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Long-Term Reduction in Peripheral Blood HIV Type 1 Reservoirs Following Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation
- (2013) T. J. Henrich et al. JOURNAL OF INFECTIOUS DISEASES
- Absence of Detectable HIV-1 Viremia after Treatment Cessation in an Infant
- (2013) Deborah Persaud et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies
- (2013) Susanne Eriksson et al. PLoS Pathogens
- Challenges in Detecting HIV Persistence during Potentially Curative Interventions: A Study of the Berlin Patient
- (2013) Steven A. Yukl et al. PLoS Pathogens
- Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study
- (2013) Asier Sáez-Cirión et al. PLoS Pathogens
- An Increasing Proportion of Monotypic HIV-1 DNA Sequences during Antiretroviral Treatment Suggests Proliferation of HIV-Infected Cells
- (2012) Thor A. Wagner et al. JOURNAL OF VIROLOGY
- Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
- (2012) N. M. Archin et al. NATURE
- Antiretroviral dynamics determines HIV evolution and predicts therapy outcome
- (2012) Daniel I S Rosenbloom et al. NATURE MEDICINE
- A quantitative basis for antiretroviral therapy for HIV-1 infection
- (2012) Benjamin L Jilek et al. NATURE MEDICINE
- HIV Model Parameter Estimates from Interruption Trial Data including Drug Efficacy and Reservoir Dynamics
- (2012) Rutao Luo et al. PLoS One
- Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection
- (2012) N. M. Archin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Developing strategies for HIV-1 eradication
- (2012) Christine M. Durand et al. TRENDS IN IMMUNOLOGY
- Standing Genetic Variation and the Evolution of Drug Resistance in HIV
- (2012) Pleuni Simone Pennings PLoS Computational Biology
- Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication
- (2010) Tae-Wook Chun et al. AIDS
- Transcriptional Bursting from the HIV-1 Promoter Is a Significant Source of Stochastic Noise in HIV-1 Gene Expression
- (2010) Abhyudai Singh et al. BIOPHYSICAL JOURNAL
- Estimation of the Initial Viral Growth Rate and Basic Reproductive Number during Acute HIV-1 Infection
- (2010) R. M. Ribeiro et al. JOURNAL OF VIROLOGY
- The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial
- (2010) Rajesh T. Gandhi et al. PLOS MEDICINE
- HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
- (2009) Nicolas Chomont et al. NATURE MEDICINE
- Long-Term Control of HIV byCCR5Delta32/Delta32 Stem-Cell Transplantation
- (2009) Gero Hütter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy
- (2009) J. B. Dinoso et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs
- (2008) Lin Shen et al. NATURE MEDICINE
- HIV rebounds from latently infected cells, rather than from continuing low-level replication
- (2008) B. Joos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection
- (2008) B. F. Keele et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started